Your search returned 2 results.

Results
	1.	University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL. [electronic resource] by Galanina, Natalie Smith, Sonali M Liao, Chuanhong Petrich, Adam Libao, Bernadette Gartenhaus, Ronald Westin, Jason R Cohen, Kenneth S Knost, James A Stadler, Walter M Doyle, Austin Karrison, Theodore Gordon, Leo I Evens, Andrew M Producer: 20190205 In: British journal of haematology vol. 181 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancer. [electronic resource] by Nanda, Rita Stringer-Reasor, Erica M Saha, Poornima Kocherginsky, Masha Gibson, Jean Libao, Bernadette Hoffman, Philip C Obeid, Elias Merkel, Douglas E Khramtsova, Galina Skor, Maxwell Krausz, Thomas Cohen, Ronald N Ratain, Mark J Fleming, Gini F Conzen, Suzanne D Producer: 20160707 In: SpringerPlus vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search